GCN June 22, 2018
Access to detailed, interoperable health information from large numbers of patients could help improve patient quality outcomes and provide medical researchers, insurance companies, public health officials and pharmaceutical manufacturers with treasure troves of data. Sharing that data, however, requires that personal health information is protected and that blockchain software can be installed across a diverse health care enterprise.
Under a pilot project with four major hospitals, the Food and Drug Administration’s Office of Translational Sciences is working with Booz Allen Hamilton to test how blockchain technology could be implemented to facilitate the secure sharing of information among the FDA, health care providers and hospitals.
“We can’t store data in blockchain when it contains [patient health information], so we needed to...
Today's Sponsors
Today's Sponsor